hypertension, chronic hear disease, post-cerebrovascular diorder
Conditions
Interventions
telemonitoring with vital sign sensor and sleep sensor
without telemonitoring with vital sign sensor and sleep sensor
Sponsors
AMED
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients provided with regular visit by the physician at least twice every month 2) Patients at risk for any of the cerebral or cardiovascular diseases as below (1) Patients with previous or current history of hypertension (2) Patients with grade II, III or IV heart failure (New York Heart Association (NYHA) severity classification), BNP over 100 pg/mL or NT-proBNP over 400 pg/mL) (3) Patients with previous history of cerebral hemorrhage, cerebral infarction, or subarachnoid hemorrhage for more than 3 months prior to enrollment 3) Patients with written informed consent to participate obtained from subjects or representatives
Exclusion criteria
Exclusion criteria: 1) Patients with cancer. 2) Patients with a previous history of coronary artery disease, vascular disease, cerebral hemorrhage, cerebral infarction, or subarachnoid hemorrhage within 3 months prior to enrollment 3) Patients with a >=50% increase in serum creatinine within 3 months prior to enrollment 4) Patients on hormone replacement therapy with estrogen (estrogenic hormone products) 5) Patients who participated in another clinical study or clinical trial in the six months prior to enrollment 6) Patients judged inappropriate for this study by the physicians in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| re-admittance due to exacerbation of heart failure, cerebrovascular disease and other cardiovascular events, and death within 9 months after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| NYHA grade BNP or NT-proBNP level cerebrovascular disease and other cardiovascular related medicine and its dose frequency of emergent doctor visit and doctor call blood pressure, pulse rate, respiratory rate satisfaction of patients, family and medical staff | — |
Countries
Japan
Contacts
Public ContactShinsuke Muto
Tetsuyu Institute Medical Corporation President
Outcome results
None listed